Lyell Immunopharma, Inc. (LYEL)
9.26
-0.15
(-1.59%)
USD |
NASDAQ |
Oct 02, 16:00
9.30
+0.04
(+0.43%)
After-Hours: 07:36
Lyell Immunopharma Market Cap : 216.66M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 216.66M |
| October 01, 2026 | 220.17M |
| September 30, 2026 | 229.06M |
| September 29, 2026 | 225.31M |
| September 28, 2026 | 227.89M |
| September 25, 2026 | 230.46M |
| September 24, 2026 | 236.78M |
| September 23, 2026 | 246.37M |
| September 22, 2026 | 260.88M |
| September 21, 2026 | 255.73M |
| September 18, 2026 | 257.60M |
| September 17, 2026 | 252.69M |
| September 16, 2026 | 252.10M |
| September 15, 2026 | 255.26M |
| September 14, 2026 | 265.09M |
| September 11, 2026 | 279.83M |
| September 10, 2026 | 285.44M |
| September 09, 2026 | 301.35M |
| September 08, 2026 | 316.56M |
| September 04, 2026 | 336.21M |
| September 03, 2026 | 335.04M |
| September 02, 2026 | 349.90M |
| September 01, 2026 | 339.84M |
| August 31, 2026 | 335.04M |
| August 28, 2026 | 339.96M |
| Date | Value |
|---|---|
| August 27, 2026 | 341.83M |
| August 26, 2026 | 346.28M |
| August 25, 2026 | 362.42M |
| August 24, 2026 | 344.87M |
| August 21, 2026 | 363.36M |
| August 20, 2026 | 359.14M |
| August 19, 2026 | 368.74M |
| August 18, 2026 | 369.44M |
| August 17, 2026 | 317.03M |
| August 14, 2026 | 326.39M |
| August 13, 2026 | 321.47M |
| August 12, 2026 | 331.54M |
| August 11, 2026 | 348.15M |
| August 10, 2026 | 335.28M |
| August 07, 2026 | 344.17M |
| August 06, 2026 | 332.47M |
| August 05, 2026 | 314.69M |
| August 04, 2026 | 318.20M |
| August 03, 2026 | 300.24M |
| July 31, 2026 | 301.87M |
| July 30, 2026 | 320.07M |
| July 29, 2026 | 302.57M |
| July 28, 2026 | 303.04M |
| July 27, 2026 | 302.34M |
| July 24, 2026 | 294.64M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 9.059B |
| Oncolytics Biotech, Inc. | 78.65M |
| Sangamo Therapeutics, Inc. | 61.11M |
| Sarepta Therapeutics, Inc. | 1.848B |
| Anixa Biosciences, Inc. | 102.02M |
Market Cap Related Metrics
| PS Ratio | 7267.33 |
| Price to Book Value | 0.9266 |
| Price | 9.26 |
| Earnings Yield | -127.1% |